PA
MERC icon

PharVision Advisers’s Mercer International MERC Stock Holding History

PharVision Advisers’s Portfolio MERC Stock Details MERC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,353
Closed -$178K – 420
2024
Q4 		$178K Buy
+27,353
New +$179K 0.15% 330

Other funds holding MERC

IR
IAT Reinsurance New York $310M AUM 13.37% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AF
Atlas FRM Greenwich, Connecticut $1.53B AUM 14.94% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15% 1-Year Est. Return

PharVision Advisers's MERC Position: Q1 2025 in Review

PharVision Advisers sold out of Mercer International (MERC) in Q1 2025, closing a stake of 27,353 shares — an estimated $178K sold.

PharVision Advisers first reported a position in MERC in Q4 2024 and held it in 1 quarter. The position peaked at $178K in Q4 2024. 112 funds tracked by Wall St. Rank hold MERC as of Q1 2025.

  • PharVision Advisers reported no remaining Mercer International position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 27,353 Mercer International shares in Q1 2025, an estimated $178K.
  • PharVision Advisers first reported a position in Mercer International in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Mercer International position peaked at $178K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Mercer International as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.